DK3723783T3 - Mitokondrie-målrettede peptider - Google Patents
Mitokondrie-målrettede peptider Download PDFInfo
- Publication number
- DK3723783T3 DK3723783T3 DK18888579.2T DK18888579T DK3723783T3 DK 3723783 T3 DK3723783 T3 DK 3723783T3 DK 18888579 T DK18888579 T DK 18888579T DK 3723783 T3 DK3723783 T3 DK 3723783T3
- Authority
- DK
- Denmark
- Prior art keywords
- mitochondria
- targeting peptides
- targeting
- peptides
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K5/00—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof
- C07K5/02—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof containing at least one abnormal peptide link
- C07K5/021—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof containing at least one abnormal peptide link containing the structure -NH-(X)n-C(=0)-, n being 5 or 6; for n > 6, classification in C07K5/06 - C07K5/10, according to the moiety having normal peptide bonds
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K5/00—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof
- C07K5/04—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof containing only normal peptide links
- C07K5/06—Dipeptides
- C07K5/06086—Dipeptides with the first amino acid being basic
- C07K5/06095—Arg-amino acid
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K38/00—Medicinal preparations containing peptides
- A61K38/04—Peptides having up to 20 amino acids in a fully defined sequence; Derivatives thereof
- A61K38/05—Dipeptides
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K38/00—Medicinal preparations containing peptides
- A61K38/04—Peptides having up to 20 amino acids in a fully defined sequence; Derivatives thereof
- A61K38/07—Tetrapeptides
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
- A61K47/50—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates
- A61K47/51—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the non-active ingredient being a modifying agent
- A61K47/62—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the non-active ingredient being a modifying agent the modifying agent being a protein, peptide or polyamino acid
- A61K47/64—Drug-peptide, drug-protein or drug-polyamino acid conjugates, i.e. the modifying agent being a peptide, protein or polyamino acid which is covalently bonded or complexed to a therapeutically active agent
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P13/00—Drugs for disorders of the urinary system
- A61P13/12—Drugs for disorders of the urinary system of the kidneys
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K5/00—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof
- C07K5/04—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof containing only normal peptide links
- C07K5/06—Dipeptides
- C07K5/06086—Dipeptides with the first amino acid being basic
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K5/00—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof
- C07K5/04—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof containing only normal peptide links
- C07K5/10—Tetrapeptides
- C07K5/1002—Tetrapeptides with the first amino acid being neutral
- C07K5/1016—Tetrapeptides with the first amino acid being neutral and aromatic or cycloaliphatic
Landscapes
- Chemical & Material Sciences (AREA)
- Health & Medical Sciences (AREA)
- Organic Chemistry (AREA)
- Life Sciences & Earth Sciences (AREA)
- General Health & Medical Sciences (AREA)
- Medicinal Chemistry (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Engineering & Computer Science (AREA)
- Molecular Biology (AREA)
- Genetics & Genomics (AREA)
- Biophysics (AREA)
- Biochemistry (AREA)
- Animal Behavior & Ethology (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- Pharmacology & Pharmacy (AREA)
- Epidemiology (AREA)
- Crystallography & Structural Chemistry (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Urology & Nephrology (AREA)
- General Chemical & Material Sciences (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Heart & Thoracic Surgery (AREA)
- Cardiology (AREA)
- Vascular Medicine (AREA)
- Gastroenterology & Hepatology (AREA)
- Immunology (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Peptides Or Proteins (AREA)
- Heterocyclic Carbon Compounds Containing A Hetero Ring Having Nitrogen And Oxygen As The Only Ring Hetero Atoms (AREA)
- Plural Heterocyclic Compounds (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US201762599175P | 2017-12-15 | 2017-12-15 | |
| PCT/US2018/065755 WO2019118878A1 (en) | 2017-12-15 | 2018-12-14 | Mitochondria-targeting peptides |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| DK3723783T3 true DK3723783T3 (da) | 2023-03-20 |
Family
ID=66819527
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| DK18888579.2T DK3723783T3 (da) | 2017-12-15 | 2018-12-14 | Mitokondrie-målrettede peptider |
Country Status (18)
| Country | Link |
|---|---|
| EP (2) | EP3723783B1 (da) |
| JP (2) | JP7335880B2 (da) |
| KR (2) | KR20240150524A (da) |
| CN (5) | CN118702767A (da) |
| AU (3) | AU2018385690B2 (da) |
| DK (1) | DK3723783T3 (da) |
| ES (1) | ES2942631T3 (da) |
| FI (1) | FI3723783T3 (da) |
| HR (1) | HRP20230261T1 (da) |
| HU (1) | HUE061271T2 (da) |
| IL (4) | IL305687B2 (da) |
| LT (1) | LT3723783T (da) |
| PL (1) | PL3723783T3 (da) |
| PT (1) | PT3723783T (da) |
| RS (1) | RS64128B1 (da) |
| SI (1) | SI3723783T1 (da) |
| SM (1) | SMT202300119T1 (da) |
| WO (1) | WO2019118878A1 (da) |
Families Citing this family (17)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| JP7638265B2 (ja) * | 2019-07-24 | 2025-03-03 | ステルス バイオセラピューティクス インコーポレイテッド | 神経変性疾患の治療におけるペプチド模倣化合物（ｒ）－２－アミノ－ｎ－（（ｓ）－ｌ－（（（ｓ）－５－アミノ－ｌ－（３－ベンジル－１，２，４－オキサジアゾール－５－イル）ペンチル）アミノ）－３－（４－ヒドロキシ－２，６－ジメチルフェニル）－ｉ－オキソプロパン－２－イル）－５－グアニジノペンタンアミド |
| IL291898B1 (en) | 2019-10-04 | 2026-06-01 | Stealth Biotherapeutics Inc | Quinone-, hydroquinone-, and naphthoquinone- analogs of quinone for the treatment of mitochondrial disorders |
| CN111040014A (zh) * | 2019-12-27 | 2020-04-21 | 苏州络森生物科技有限公司 | 一种chapso的制备方法 |
| CA3176909A1 (en) | 2020-04-03 | 2021-10-07 | Stealth Biotherapeutics Inc. | Compositions and methods for the prevention and/or treatment of mitochondrial disease, including friedreich's ataxia |
| US20230227499A1 (en) * | 2020-06-22 | 2023-07-20 | Stealth Biotherapeutics Inc. | Prodrugs of mitochondria-targeting oligopeptides |
| US20230279052A1 (en) * | 2020-06-22 | 2023-09-07 | Stealth Biotherapeutics Inc. | Prodrugs of mitochondria-targeting oligopeptides |
| CN112876502B (zh) * | 2021-02-09 | 2022-01-11 | 上海嘉莱多生物技术有限责任公司 | 一种n-三甲基硅乙氧羰基-n-甲基-l/d-亮氨酸的制备方法 |
| CN113372278A (zh) * | 2021-06-09 | 2021-09-10 | 吉尔多肽生物制药(大连市)有限公司 | 一种Nα-叔丁氧羰基-Nim-对甲苯磺酰基-L-组氨酸的合成方法 |
| AU2022291142A1 (en) | 2021-06-10 | 2023-12-21 | Stealth Biotherapeutics Inc. | Compounds, compositions and methods for the prevention and/or treatment of various mitochondrial diseases or disorders, including friedreich's ataxia |
| JP2025001049A (ja) * | 2021-09-01 | 2025-01-08 | 積水メディカル株式会社 | アルギニン誘導体 |
| WO2023069549A1 (en) * | 2021-10-20 | 2023-04-27 | Stealth Biotherapeutics Inc. | Methods and compositions comprising peptidomimitics for treating, preventing, inhibiting, ameliorating or delaying the onset of ophthalmic conditions |
| WO2023069255A1 (en) | 2021-10-20 | 2023-04-27 | Stealth Biotherapeutics Inc. | Methods and compositions comprising peptidomimitics for treating, preventing, inhibiting, ameliorating or delaying the onset of ophthalmic conditions |
| JP2025503652A (ja) | 2022-01-10 | 2025-02-04 | ステルス バイオセラピューティクス インコーポレイテッド | タウオパチーの治療のための小分子ペプチドミメティック |
| CN119497612A (zh) * | 2022-05-18 | 2025-02-21 | 康德生物医疗有限公司 | 用于治疗亨廷顿病和htt蛋白病的组合物和方法 |
| CN117137885A (zh) * | 2023-08-29 | 2023-12-01 | 浙江大学 | 一种基于米屈肼衍生物的脂质纳米颗粒及其应用 |
| KR102681736B1 (ko) | 2023-10-05 | 2024-07-05 | 주식회사지온 | 치과용 어버트먼트 어셈블리 |
| KR102693547B1 (ko) | 2023-12-19 | 2024-08-09 | 주식회사 지온 | 치과용 어버트먼트 어셈블리 |
Family Cites Families (10)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| JP3507486B2 (ja) | 1991-03-15 | 2004-03-15 | アムジエン・インコーポレーテツド | 顆粒球コロニー刺激因子の肺内投与 |
| US5451569A (en) | 1994-04-19 | 1995-09-19 | Hong Kong University Of Science And Technology R & D Corporation Limited | Pulmonary drug delivery system |
| WO2011087758A1 (en) * | 2009-12-22 | 2011-07-21 | H. Lundbeck A/S | Adamantyl amide derivatives and uses of same |
| US20130195837A1 (en) | 2009-12-31 | 2013-08-01 | Stealth Peptides International, Inc. | Methods for the prevention or treatment of vessel occlusion injury |
| JP2013532124A (ja) | 2010-05-03 | 2013-08-15 | ステルス ペプチドズ インターナショナル インコーポレイテッド | 芳香族系陽イオンペプチド及びその使用 |
| CN103249423A (zh) * | 2010-07-09 | 2013-08-14 | 康肽德生物医药技术有限公司 | 预防或治疗缺血/再灌注损伤之后无复流的方法 |
| CN107496899A (zh) * | 2011-09-29 | 2017-12-22 | 梅约医学教育与研究基金会 | 芳族阳离子肽和使用它们的方法 |
| CA3113959A1 (en) * | 2012-09-26 | 2014-04-03 | President And Fellows Of Harvard College | Proline-locked stapled peptides and uses thereof |
| CA2916492A1 (en) | 2013-06-27 | 2014-12-31 | Stealth Biotherapeutics Corp | Peptide therapeutics and methods for using same |
| HUE054626T2 (hu) * | 2014-06-25 | 2021-09-28 | Flamma Spa | Eljárás D-arginil-2,6-dimetil-L-tirozil-L-lizil-L-fenilalaninamid elõállítására |
-
2018
- 2018-12-14 IL IL305687A patent/IL305687B2/en unknown
- 2018-12-14 IL IL300697A patent/IL300697B2/en unknown
- 2018-12-14 CN CN202410716131.3A patent/CN118702767A/zh active Pending
- 2018-12-14 DK DK18888579.2T patent/DK3723783T3/da active
- 2018-12-14 RS RS20230287A patent/RS64128B1/sr unknown
- 2018-12-14 SM SM20230119T patent/SMT202300119T1/it unknown
- 2018-12-14 HR HRP20230261TT patent/HRP20230261T1/hr unknown
- 2018-12-14 HU HUE18888579A patent/HUE061271T2/hu unknown
- 2018-12-14 PL PL18888579.2T patent/PL3723783T3/pl unknown
- 2018-12-14 EP EP18888579.2A patent/EP3723783B1/en active Active
- 2018-12-14 LT LTEPPCT/US2018/065755T patent/LT3723783T/lt unknown
- 2018-12-14 SI SI201830867T patent/SI3723783T1/sl unknown
- 2018-12-14 IL IL314515A patent/IL314515A/en unknown
- 2018-12-14 EP EP23155684.6A patent/EP4218785A3/en active Pending
- 2018-12-14 WO PCT/US2018/065755 patent/WO2019118878A1/en not_active Ceased
- 2018-12-14 PT PT188885792T patent/PT3723783T/pt unknown
- 2018-12-14 CN CN202311619826.1A patent/CN117624286A/zh active Pending
- 2018-12-14 CN CN202410716124.3A patent/CN118725014A/zh active Pending
- 2018-12-14 ES ES18888579T patent/ES2942631T3/es active Active
- 2018-12-14 CN CN202410716120.5A patent/CN118702766A/zh active Pending
- 2018-12-14 CN CN201880089496.0A patent/CN111954539B/zh active Active
- 2018-12-14 KR KR1020247032715A patent/KR20240150524A/ko active Pending
- 2018-12-14 AU AU2018385690A patent/AU2018385690B2/en active Active
- 2018-12-14 KR KR1020207020384A patent/KR102714781B1/ko active Active
- 2018-12-14 JP JP2020532945A patent/JP7335880B2/ja active Active
- 2018-12-14 FI FIEP18888579.2T patent/FI3723783T3/fi active
-
2020
- 2020-06-11 IL IL275298A patent/IL275298B2/en unknown
-
2023
- 2023-07-12 AU AU2023204607A patent/AU2023204607B2/en active Active
- 2023-08-18 JP JP2023133575A patent/JP7576670B2/ja active Active
-
2025
- 2025-11-13 AU AU2025267434A patent/AU2025267434A1/en active Pending
Also Published As
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| IL268920A (en) | Peptide vaccines | |
| DK3731771T3 (da) | V462033dk00 | |
| PL3727460T3 (pl) | Bicykliczne ligandy peptydowe swoiste wobec epha2 | |
| CL2018000524S1 (es) | Golilla | |
| EP3589248A4 (en) | CRYOTHERAPIES | |
| DE202018003363U8 (de) | Handgelenkssphygmomanometer | |
| EP3634404C0 (en) | PYRAZOLE-BASED MAGL INHIBITORS | |
| EP3697802A4 (en) | TRITERPENIC SAPONIN ANALOGUES | |
| EP3588580A4 (en) | SCHOTTKY MOS TRENCH DIODE | |
| DK3351526T3 (da) | Diisopentylterephthalat | |
| EP3634397A4 (en) | HETEROCYCLYL-POLYMETHINIR-IR-CHROMOPHORE | |
| EP3721165C0 (en) | MILITARY CHARGE | |
| EP3654852A4 (en) | TOURNIQUET | |
| DK3568655T3 (da) | Rekuperator | |
| DK3571580T3 (da) | Load-logical-and-shift-guarded-instruktion | |
| DK3612237T3 (da) | Genterapi | |
| EP3611402A4 (en) | SERVO CYLINDER | |
| EP3615471A4 (en) | PLASMA PHOTOELECTRONIC IMMUNE SENSOR | |
| DK3448879T3 (da) | Claudin-6 peptider | |
| EP3669219C0 (en) | NETWORK SCALE | |
| EP3714787A4 (en) | BIOSENSOR | |
| DK3576686T3 (da) | Brokbind | |
| DK3568506T3 (da) | Offeranode | |
| EP3689701A4 (en) | BOGIE | |
| IT201700080068A1 (it) | Peptidi antimicrobici |